Literature DB >> 14962481

Role of clinical pathologies in myocardial injury following ischaemia and reperfusion.

Manuel Galiñanes1, Alan G Fowler.   

Abstract

The myocardial injury that occurs following a period of ischaemia and reperfusion is well recognised and the underlying mechanisms have been extensively investigated in healthy myocardial tissues; however, the influence of the risk factors associated with cardiovascular diseases on ischaemia/reperfusion injury remains unclear. In this article, the present knowledge on how clinical pathologies such as diabetes, hypercholesterolaemia, hypertension, myocardial hypertrophy and heart failure may influence ischaemia/reperfusion injury of the heart and the potential mechanisms involved are reviewed.

Entities:  

Mesh：

Year:  2004        PMID： 14962481     DOI： 10.1016/j.cardiores.2003.11.028

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


  16 in total

Review 1.  Contribution of apoptosis in myocardial reperfusion injury and loss of cardioprotection in diabetes mellitus.

Authors:  Reza Badalzadeh; Behnaz Mokhtari; Raana Yavari
Journal:  J Physiol Sci       Date:  2015-03-01       Impact factor: 2.781

2.  Impaired cardiac ischemic tolerance in spontaneously hypertensive rats is attenuated by adaptation to chronic and acute stress.

Authors:  T Ravingerová; I Bernátová; J Matejíková; V Ledvényiová; M Nemčeková; O Pecháňová; N Tribulová; J Slezák
Journal:  Exp Clin Cardiol       Date:  2011

3.  Subcellular mechanisms of adaptation in the diabetic myocardium: Relevance to ischemic preconditioning in the nondiseased heart.

Authors:  T Ravingerová; A Adameová; J Matejíková; T Kelly; M Nemčeková; J Kucharská; O Pecháňová; A Lazou
Journal:  Exp Clin Cardiol       Date:  2010

4.  Hypercholesterolemia abrogates an increased resistance of diabetic rat hearts to ischemia-reperfusion injury.

Authors:  A Adameová; M Kuzelová; E Andelová; V Faberová; D Pancza; P Svec; A Ziegelhöffer; T Ravingerová
Journal:  Mol Cell Biochem       Date:  2006-08-10       Impact factor: 3.396

5.  Hypercholesterolemia is associated with hyperactive cardiac mTORC1 and mTORC2 signaling.

Authors:  Hilary P Glazer; Robert M Osipov; Richard T Clements; Frank W Sellke; Cesario Bianchi
Journal:  Cell Cycle       Date:  2009-06-03       Impact factor: 4.534

6.  Effect of hypercholesterolemia on myocardial necrosis and apoptosis in the setting of ischemia-reperfusion.

Authors:  Robert M Osipov; Cesario Bianchi; Jun Feng; Richard T Clements; Yuhong Liu; Michael P Robich; Hilary P Glazer; Neel R Sodha; Frank W Sellke
Journal:  Circulation       Date:  2009-09-15       Impact factor: 29.690

7.  Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention--a retrospective nationwide cohort study.

Authors:  Casper H Jørgensen; Gunnar H Gislason; Charlotte Andersson; Ole Ahlehoff; Mette Charlot; Tina K Schramm; Allan Vaag; Steen Z Abildstrøm; Christian Torp-Pedersen; Peter R Hansen
Journal:  Cardiovasc Diabetol       Date:  2010-09-16       Impact factor: 9.951

8.  Type 2 diabetes mellitus and myocardial ischemic preconditioning in symptomatic coronary artery disease patients.

Authors:  Paulo Cury Rezende; Rosa Maria Rahmi; Augusto Hiroshi Uchida; Leandro Menezes Alves da Costa; Thiago Luis Scudeler; Cibele Larrosa Garzillo; Eduardo Gomes Lima; Carlos Alexandre Wainrober Segre; Priscyla Girardi; Myrthes Takiuti; Marcela Francisca Silva; Whady Hueb; Jose Antonio Franchini Ramires; Roberto Kalil Filho
Journal:  Cardiovasc Diabetol       Date:  2015-05-30       Impact factor: 9.951

9.  Social deprivation and prognostic benefits of cardiac surgery: observational study of 44 902 patients from five hospitals over 10 years.

Authors:  D Pagano; N Freemantle; B Bridgewater; N Howell; D Ray; M Jackson; B M Fabri; J Au; D Keenan; B Kirkup; B E Keogh
Journal:  BMJ       Date:  2009-04-02

10.  Susceptibility to myocardial ischemia reperfusion injury at early stage of type 1 diabetes in rats.

Authors:  Haobo Li; Zipeng Liu; Junwen Wang; Gordon T Wong; Chi-Wai Cheung; Liangqing Zhang; Can Chen; Zhengyuan Xia; Michael G Irwin
Journal:  Cardiovasc Diabetol       Date:  2013-09-17       Impact factor: 9.951
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.